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Abstract
Background—A disproportionately high percentage of trauma patients use controlled 
substances, and they often co-ingest multiple drugs. Previous studies have evaluated the effect of 
individual drugs on clinical outcomes following trauma. However, the impact of all drugs included 
in a comprehensive screening panel has not yet been compared in a single cohort of patients.
Methods—All trauma patients who underwent urine drug screens following admission to the 
LAC+USC Medical Center (01/2008-06/2015) were identified retrospectively. Univariable and 
multivariable regression analyses determined the significance of all drugs tested in the hospital’s 
standard toxicology screen (amphetamine, barbiturate, benzodiazepine, cocaine, opiate, 
phencyclidine) on clinical outcomes.
Results—A total of 10,288 patients who underwent admission toxicology screening were 
identified. While 5,661 patients had completely negative screens, 3,370 patients tested positive for 
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only one drug and 1,257 patients tested for multiple drugs. Univariable analysis indicated that 
patients who tested positive for multiple drugs had higher rates of operative intervention 
(p<0.001), longer hospital stay (p<0.001), and longer ICU stays (p<0.001). Multivariable analysis 
indicated that phencyclidine was associated with higher rates of mortality (p=0.028) while 
amphetamine was associated with lower rates of mortality (p=0.008). Higher rates of operative 
intervention were observed in patients testing positive for amphetamine (p<0.001), benzodiazepine 
(p<0.001), or opiate (p<0.001). Benzodiazepine use was associated with higher rates of 
mechanical ventilation (p<0.001), but use of amphetamines (p=0.030) or opiates (p<0.001) was 
associated with lower rates.
Conclusions—Pre-injury use of amphetamine, barbiturate, benzodiazepine, cocaine, opiate, and 
PCP have significant and variable impact on clinical outcomes following trauma. Comparing the 
relative effect of each drug class can help clinicians risk-stratify all trauma patients, including 
those who test positive for multiple substances.
Keywords
Trauma; Outcomes; Toxicology; Controlled Substance
Background
Controlled substance use has dramatically escalated in the last two decades. Between 1999 
and 2002, US prescriptions for oxycodone, morphine, and fentanyl increased by 50%, 60%, 
and 150%, respectively (1-3). Likewise, amphetamine prescriptions doubled between 1994 
and 2004 (4). More recently from 2007 to 2011, total US opiate, benzodiazepine, and 
amphetamine prescriptions grew 17%, 16%, and 39% (5). The increasing number of 
controlled substance prescriptions reflects not only the amplified use by existing patients but 
also an expanding population of users (6, 7). In particular, misuse and abuse of both 
prescription and illegal drugs have increased 13% (8). Consequently, healthcare providers 
must care for an increasing number of patients illicitly using controlled substances.
Controlled substance use is especially prominent in patients admitted for traumatic injury (3, 
9). In response to the growing prevalence of drug use, investigators have examined the 
relationship between pre-injury use of amphetamine (10-14), benzodiazepine (15), cocaine 
(16-21), and opiate (22) with injury patterns and clinical outcomes. However, even within a 
single drug class, studies have reported conflicting relationships between pre-injury 
controlled substance use and mortality, operative intervention, mechanical ventilation, 
hospital length of stay (LOS), and intensive care unit (ICU) LOS.
To further obscure the characterization of clinical outcomes in patients who use drugs, illicit 
drug use frequently involves concurrent use of multiple substances. Previous studies have 
focused on one drug, often inconsistently accounting for patients testing positive for a 
variety of drugs. In fact, these studies often excluded patients testing positive for alcohol, 
one of the most common co-ingestants (10, 22, 23). The authors of the present study 
hypothesize that the clinical outcomes following traumatic injury of patients who test 
positive for a controlled substance differ significantly not only from those of patients who 
test negative for all controlled substances, but also from the outcomes of patients who test 
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positive for other controlled substances. Therefore, the purpose of the present study was to 
evaluate the impact of amphetamine, barbiturate, benzodiazepine, cocaine, opiate, and 
phencyclidine (PCP) on clinical outcomes following trauma. By comprehensively 
incorporating all results of admission urine toxicology screening, this study aims to compare 
the relative impact of each controlled substance. Furthermore, the study also assesses the 
impact of concurrent alcohol use on the association between pre-injury controlled substance 
use and clinical outcomes.
Methods
Patient Selection
The Institutional Review Board of the University of Southern California Health Sciences 
Campus approved this project. This single-center, retrospective observational study included 
all trauma patients 13 years and older who were admitted to the LAC+USC Medical Center 
between January 1, 2008, and July 31, 2015. All trauma patients who underwent an 
admission urine toxicology screen were included. Routine urine toxicology panels tested for 
the presence of amphetamine, barbiturate, benzodiazepine, cocaine, opiate, and PCP without 
quantification. Although quantified drug levels were reported in a few unique cases, routine 
urine toxicology screens report only a binary result, positive or negative, depending on 
whether a threshold urine concentration is met. To reflect this clinical practice, the present 
study analyzes controlled substance use as a binary variable. Admission blood alcohol level 
(BAL) data were extracted and maintained as a continuous variable because this data were 
primarily reported as a continuous level for clinicians.
Additionally, patient characteristics including age, sex, admission systolic blood pressure 
(SBP), admission Glasgow Coma Score (GCS), Injury Severity Score (ISS), Abbreviated 
Injury Scale (AIS) by body part, and mechanism of injury were also collected. Mechanism 
of injury was categorized as penetrating, blunt, other (e.g., burn), or a combination of the 
three. Clinical outcome variables included mortality, operative intervention, mechanical 
ventilation, ICU admission, hospital LOS, and ICU LOS.
Statistical Analysis
The significance of pre-injury controlled substance use on outcome variables was 
determined using both univariate and multivariate regression analyses. In univariate analysis, 
patients were stratified into eight mutually exclusive groups determined by urine toxicology 
screening results: completely negative, amphetamine-positive only, barbiturate-positive only, 
benzodiazepine-positive only, cocaine-positive only, opiate-positive only, PCP-positive only, 
and poly-drug-positive. The chi-square test of independence with post hoc Bonferroni 
correction (α = 0.05) was used to examine associations between drug group and 
dichotomous outcome variables (mortality, operative intervention, mechanical ventilation, 
and ICU admission). One-way analysis of variance (ANOVA) with post hoc Bonferroni 
correction (α = 0.05) was used to examine associations between drug group and continuous 
outcome variables (ICU LOS and hospital LOS).
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Multivariable analysis adjusted for differences in patient characteristics including age, sex, 
admission SBP, admission GCS, ISS, and mechanism of injury. GCS was used in lieu of AIS 
for three reasons. First, GCS is a more objective measurement than AIS. Second, GCS has 
been consistently used in previous literature assessing controlled substances in trauma 
patients (10, 16, 18, 19). Third, GCS has been validated as an appropriate indicator of 
traumatic brain injury despite intoxication in trauma patients (24).
For multivariate analysis, urine drug screen results for each controlled substance were 
characterized as binary variables (i.e., positive or negative). The main effects of controlled 
substances were simultaneously included in logistic and linear regression models to assess 
their significance as predictors of dichotomous and continuous outcome variables, 
respectively. Before linear regression analysis, satisfaction of all statistical assumptions 
necessary for linear regression was confirmed. This entailed transforming hospital LOS and 
ICU LOS via base 10 logarithmic (log10) transformation. Regression model performance 
were also tested. For logistic regression, calibration and discrimination were examined with 
the Hosmer and Lemeshow Test and area under the receiver operating characteristic (ROC) 
curve. For linear regression, R2 coefficients were examined.
Pairwise interactions were also examined in multivariate analysis adjusting for differences in 
patient characteristics. This was performed to determine whether use of each substance 
remained significant in the presence of others, and to assess any synergistic or antagonistic 
effects of combination drug use.
Data were managed and analyzed using SPSS version 23 (IBM Corporation, Armonk, NY).
Subgroup Analysis
Subgroup analysis was conducted for patients who underwent admission blood alcohol 
screening. BAL data were maintained as a continuous variable. The multivariate analyses of 
each controlled substance controlling for patient characteristics were repeated with blood 
alcohol level included as a continuous independent predictor of clinical outcomes.
Results
During the study timeframe, 10,166 patients satisfied inclusion criteria (Figure 1). Patient 
age ranged from 13 to 103 years (mean 39.2; standard deviation [SD] 16.8). Of all patients, 
8,076 (79.3%) were male. The median ISS and GCS at admission were 5.0 (interquartile 
range [IQR] 2.0-13.0) and 15.0 (IQR 14.0-15.0), respectively. Overall, 8,465 (83.3%) and 
1,735 (17.1%) patients were admitted for blunt and penetrating injuries respectively; 18 
(0.2%) sustained other types of injuries (e.g., burn, electrical shock; Table 1). The most 
common mechanisms of injury were motor vehicle collision (2,581 patients, 25.3%), falls 
(2,507 patients, 24.7%), pedestrian or bicyclist thrown or run over (1,520 patients, 15.0%), 
assault (861 patients, 8.5%), and stabbing (824 patients, 8.1%; Table 2).
Of all patients, 5,621 patients (55.3%) had completely negative urine toxicology screens and 
4,545 patients (44.7%) tested positive for at least one controlled substance. Of the patients 
who had positive urine toxicology screens, opiate was the most frequently used controlled 
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substance (2,268 patients, 49.9%), followed by amphetamine (1,393 patients, 30.6%), 
benzodiazepine (1,085 patients, 23.9%), cocaine (1,019 patients, 22.4%), PCP (130 patients, 
2.9%), and barbiturate (126 patients, 2.8%). Furthermore, 3,292 patients (72.4%) tested 
positive for only one drug class while 1,253 patients (27.6%) tested positive for multiple 
controlled substances. Of patients in the former group, 754 patients (22.9%) used 
amphetamine, 63 patients (1.9%) barbiturate, 501 patients (15.2%) benzodiazepine, 553 
patients (16.8%) cocaine, 1,368 patients (41.6%) opiate, and 53 patients (1.6%) PCP. Of all 
patients, 5,987 patients underwent BAL testing (Figure 1). Positive alcohol screens were 
identified in 3,276 patients (54.7%).
Univariate analysis indicated a significant difference in all clinical outcomes assessed across 
all drug categories (Table 3). Even after adjusting for age, sex, admission SBP, admission 
GCS, ISS, and mechanism of injury in multivariate analysis, pre-injury controlled substance 
use was a significant predictor of all clinical outcomes (Table 4). Characterization of each 
controlled substance as a risk or protective factor varied across dichotomous outcomes. All 
controlled substances were associated with prolonged hospital LOS and ICU LOS. In 
subgroup analysis, BAL did not represent a significant predictor for any clinical outcome 
tested.
The Hosmer and Lemeshow Test statistics for logistic model calibration were χ2 (with 8 
degrees of freedom [d.f.])=156.279 (p<0.001) for operative intervention, χ2 (8 d.f.)= 6.492 
(p=0.592) for mortality, χ2 (8 d.f.)= 247.873 (p<0.001) for ICU admission, and χ2 (8 d.f.)= 
247.873 (p<0.001) for mechanical ventilation use. Area under the ROC curve for logistic 
model discrimination were 0.830 for operative intervention, 0.965 for mortality, 0.786 for 
ICU admission, and 0.869 for mechanical ventilation use. In linear regression models for 
continuous outcomes, R2=0.246 and R2=0.381 for hospital LOS and ICU LOS, respectively.
Multivariate examination of pairwise interaction effects indicated a significant effect of 
benzodiazepine and opiate together on operative intervention (ORBENZ 3.089 p<0.001; 
OROPIA 2.679, p<0.001; ORBENZ*OPIA 0.570, p=0.001), mortality (ORBENZ 0.498 p=0.004; 
OROPIA 0.484, p=0.011; ORBENZ*OPIA 5.068, p=0.001), Log10(Hospital LOS) (RCBENZ 
0.219 p<0.001; RCOPIA 0.106, p<0.001; RCBENZ*OPIA −0.103, p<0.001), and Log10(ICU 
LOS) (RCBENZ 0.203 p<0.001; RCOPIA 0.170, p<0.001; RCBENZ*OPIA −0.126, p=0.007). In 
other words, concurrent benzodiazepine and opiate use was associated with higher mortality, 
and likely therefore lower rates of operative intervention, shorter hospital LOS, and shorter 
ICU LOS. In addition, there was a significant effect of amphetamine and barbiturate together 
on mortality (ORAMPH 0.467 p=0.006; ORBARB 0.927, p=0.920; ORAMPH*BARB 22.768, 
p=0.022) and Log10(Hospital LOS) (RCAMPH 0.043 p<0.001; RCBARB 0.198, p<0.001; 
RCAMPH*BARB −0.181, p=0.040). Similar to the combination of benzodiazepine and opiate 
use, concurrent amphetamine and barbiturate use were associated with higher mortality and 
shorter hospital LOS.
Discussion
Prior to the present study, published literature examining the impact of pre-injury controlled 
substance use on clinical outcomes following trauma have each focused on a limited number 
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of drugs. Specifically, studies investigating pre-injury amphetamine use have reported 
inconsistent results. Pre-injury amphetamine use has been significantly associated with 
increased LOS (13), increased mortality (11), and increased ICU admission (10). However, 
both the significance and directional trend of these differences varied across studies (10-14). 
Although the present study also found that amphetamine-positivity was significantly 
associated with longer LOS, it was also associated with lower mortality and decreased ICU 
admission. A ten year difference in study time frame represents a possible explanation for 
this discrepancy. During the late 2000’s amphetamine prescriptions for Attention Deficit 
Hyperactivity Disorder increased dramatically. Thus, the present study examines a 
fundamentally different patient population than those of previous studies (5).
The results of the present study also correspond well with previous studies of pre-injury 
benzodiazepine, cocaine, and opiate use. Consistent with the results of the current study, a 
recent study found increased LOS, increased ICU LOS, and increased mechanical 
ventilation in benzodiazepine-positive patients (15). Before this study, pre-injury cocaine use 
has not been established as a significant predictor of outcomes following trauma (16-19, 21). 
However, a combination of cocaine and ethanol yields the toxic metabolic cocaethylene, 
which has been significantly associated with increased ICU admission (20). In the present 
study, cocaine use was associated with longer ICU LOS after adjusting for differences in 
patient characteristics, but this effect was not significantly impacted by concurrent alcohol 
use. Another recent study found a significant association between pre-injury opiate use and 
increased LOS following trauma, but only in less severely injured patients with ISS<15 (22). 
After controlling for ISS among other patient characteristics, the present study also 
identified a significant association between opiate use and increased LOS.
The current study identified a greater number of significant associations between each 
controlled substance and clinical outcomes following trauma compared to previously 
published investigations. This dissimilarity may be attributed to a difference in statistical 
power across studies. In comparison to other single center investigations, the present study 
assessed a substantially larger patient population with a greater number of patients testing 
positive for each drug.
This is the first clinical outcomes study to include all controlled substances tested in a 
standard admission urine toxicology screen. Its results indicate a high prevalence of pre-
injury controlled substance use in trauma patients. Additionally, trauma patients frequently 
use multiple drugs prior to presentation. In fact, patients testing positive for at least two 
controlled substances outnumber patients who test positive for any one specific controlled 
substance. Since the previously published literature tends to focus on an individual drug 
class and often excludes patients testing for multiple drugs, they fail to represent a 
substantial segment of drug-positive trauma patients. By including poly-drug-positive 
patients, the present study is able to create a more comprehensive model characterizing 
trauma patients who use controlled substances. Furthermore, the present study identified 
significant pairwise interactions between benzodiazepine and opiate use, as well as 
amphetamine and barbiturate use. Both of these pairwise interactions were associated with 
substantially higher rates of mortality than any of their constituent controlled substances 
alone. In fact, benzodiazepine and opiate use were protective against mortality when used 
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alone, but their combination was associated with one of the highest OR identified in the 
study (ORBENZ*OPIA 5.068, p=0.001).
The current study is also the first study to compare the relative impact of each controlled 
substance on clinical outcomes following trauma. After adjusting for differences in patient 
characteristics, a comparison of main effects odds ratios and regression coefficients indicates 
that PCP has the greatest impact on mortality compared to other controlled substances. 
Similarly, benzodiazepine use contributes the greatest effect on operative intervention, ICU 
admission, mechanical ventilation, hospital LOS, and ICU LOS in comparison to other 
drugs.
Several limitations concern the present study. First, although all drugs included in the 
hospital’s standard urine toxicology screen were included for analysis, the standard screen 
does not comprehensively capture all drugs. For example, cannabinoids are not included in 
the standard panel and must be ordered separately; therefore the present study did not 
include these drugs in its analysis. Nonetheless, the present study builds upon previous 
studies, which have examined a limited subset of controlled substances typically included in 
a standard urine toxicology screen. Second, use of controlled substances was analyzed as 
binary variables instead of continuous drug levels. Although this methodology practically 
incorporates the information available to most clinicians, it precludes analysis of a dose-
dependent relationship between controlled substances and outcomes. Third, urine toxicology 
and blood alcohol panels are routinely ordered only for patients with altered mental status; 
for all other patients, these admission screens are ordered at the discretion of the evaluating 
trauma team. Due to the retrospective design of the current study, some data are absent, and 
not all patients who used controlled substances prior to presentation were captured in this 
study. This may introduce some selection bias and represents a weakness of this study.
Another potential study weakness concerns the regression models’ somewhat low predictive 
power. In the case of linear regression models for hospital LOS and ICU LOS, low R2 values 
(0.246 and 0.381, respectively) suggest the models account for only a modest fraction of the 
variation in the two clinical outcomes. Indeed, patients suffering from trauma are complex, 
and their hospital LOS and ICU LOS are likely influenced by many factors unaccounted for 
in this study’s regression models. In the context of the present study, analyzing regression 
coefficients is useful for evaluating directional trends and comparing the relative impact of 
each controlled substance. Computing quantitative predictions of clinical outcomes would 
not be clinically practical. Instead, the results of multivariable analysis should be interpreted 
in a broader sense: benzodiazepine, barbiturate, opiate, cocaine, and amphetamine use are 
associated with longer LOS, while barbiturate, benzodiazepine, and opiate use are associated 
with longer ICU LOS.
Similarly, calibration of logistic regression models for operative intervention (p<0.001), ICU 
admission (p<0.001), and ventilator use (p<0.001) suggest a significant difference between 
predicted and observed mortality rates across the entire study population; only calibration of 
the logistic regression model for mortality (p=0.592) indicated robust goodness of fit. 
Studies with large sample sizes frequently fail the Hosmer and Lemeshow Test, and “a 
significant Hosmer-Lemeshow test does not necessarily mean that a predictive model is not 
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useful or suspect” (25). In fact, discrimination of logistic regression models for all clinical 
outcomes were excellent. Area under the ROC curves for operative intervention, mortality, 
ICU admission, and mechanical ventilation use were 0.830, 0.965, 0.786, and 0.869, 
respectively. This indicates high sensitivity and specificity for all logistic regression models.
Knowledge of the relationship between specific drugs and outcomes like operative 
intervention or mechanical ventilation can help clinicians identify which patients are likely 
to require these treatments before they are emergently needed. Patients sustaining traumatic 
injury are often characterized by fluctuating stability and evolving clinical needs. For 
example, a benzodiazepine-positive patient may not necessarily require mechanical 
ventilation immediately after traumatic injury. However, as patients who test positive for 
benzodiazepine are more likely to require ventilator support compared to patients who test 
negative, the results of the present study may enhance the efficiency and speed at which 
ventilation need is identified in these patients.
Furthermore, recognizing the prognostic value of drug positivity can help risk stratify 
patients and help clinicians optimize patient care. Patients testing positive for amphetamine 
are 0.5 times less likely to die than patients testing negative while patients testing positive 
for barbiturate are 1.9 times more likely to die than those testing negative. Knowledge of 
patients’ use of these drugs can help clinicians efficiently allocate their focus. Maintaining 
an equal level of vigilance for each individual patient regardless of their health status—drug 
positivity included—is neither ideal nor practical.
In conclusion, as use of controlled substances continues to increase, healthcare providers 
must care for a growing population of patients under their influence. Trauma patients 
frequently present with positive toxicology screens for at least one drug. There exists a need 
to better characterize these patients and identify those at highest risk of adverse clinical 
outcomes. The results presented herein suggest that pre-injury use of amphetamine, 
barbiturate, benzodiazepine, cocaine, opiate, and PCP have significant and variable impact 
on clinical outcomes following trauma. Recognition of these patterns may help clinicians 
risk-stratify trauma patients and efficiently anticipate and allocate their limited resources.
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Table 4
Multivariable Regression of Outcomes with Pre-injury Controlled Substance Main Effects as Predictors





Operative Intervention Amphetamine 1.327 — 1.144 to 1.541 <0.001
Barbiturate 0.518 — 0.275 to 0.977 0.042
Benzodiazepine 2.541 — 2.173 to 2.972 <0.001
Cocaine 1.127 — 0.947 to 1.341 0.179
Opiate 2.446 — 2.170 to 2.757 <0.001
PCP 0.412 — 0.224 to 0.759 0.004
Mortality Amphetamine 0.498 — 0.290 to 0.856 0.012
Barbiturate 1.419 — 0.410 to 4.909 0.580
Benzodiazepine 0.715 — 0.477 to 1.073 0.105
Cocaine 0.818 — 0.477 to 1.403 0.466
Opiate 0.792 — 0.505 to 1.243 0.311
PCP 3.488 — 1.167 to 10.43 0.025
ICU Admission Amphetamine 0.732 — 0.614 to 0.873 0.001
Barbiturate 1.622 — 1.039 to 2.532 0.033
Benzodiazepine 1.919 — 1.640 to 2.245 <0.001
Cocaine 0.786 — 0.646 to 0.958 0.017
Opiate 0.808 — 0.701 to 0.932 0.003
PCP 0.845 — 0.493 to 1.448 0.539
Mechanical Ventilation Amphetamine 0.738 — 0.569 to 0.956 0.021
Barbiturate 0.950 — 0.455 to 1.984 0.891
Benzodiazepine 3.327 — 2.729 to 4.056 <0.001
Cocaine 0.789 — 0.587 to 1.060 0.116
Opiate 0.497 — 0.389 to 0.636 <0.001
PCP 1.189 — 0.575 to 2.460 0.640
Log10(Hospital Length of Stay) Amphetamine — 0.031 0.010 to 0.052 0.004
Barbiturate — 0.142 0.077 to 0.207 <0.001
Benzodiazepine — 0.181 0.157 to 0.205 <0.001
Cocaine — 0.037 0.013 to 0.061 0.003
Opiate — 0.090 0.072 to 0.108 <0.001
PCP — 0.002 −0.062 to 0.066 0.940
Log10(ICU Length of Stay) Amphetamine — 0.002 −0.042 to 0.046 0.929
Barbiturate — 0.140 0.021 to 0.259 0.021
Benzodiazepine — 0.170 0.131 to 0.209 <0.001
Cocaine — 0.051 −0.002 to 0.104 0.057
Opiate — 0.139 0.100 to 0.178 <0.001
PCP — 0.077 −0.058 to 0.213 0.263
Multivariable analysis adjusted for age, sex, admission systolic blood pressure, admission Glasgow Coma Score, Injury Severity Score, and 
mechanism of injury.
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